Forte Biosciences (FBRX) Change in Cash (2016 - 2026)

Forte Biosciences (FBRX) has 11 years of Change in Cash data on file, last reported at -$18.7 million in Q1 2026.

• Change in Cash for Q1 2026 came in at -$18.7 million, down 179.34% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.4 million (down 19.76% YoY), and the FY2025 annual result was $54.7 million, up 467.67% from the prior year.
• Change in Cash declined to -$18.7 million in Q1 2026 per FBRX's latest filing, from -$16.5 million in the prior quarter.
• Over five years, Change in Cash peaked at $60.3 million in Q2 2025 and troughed at -$18.7 million in Q1 2026.
• A 5-year average of $951705.9 and a median of -$5.2 million in 2023 frame the typical range for Change in Cash.
• The sharpest annual moves came in 2023 and 2025: Change in Cash tumbled 939.95% in 2023, then surged 1113.93% in 2025.
• A 5-year view of Change in Cash shows it stood at -$2.9 million in 2022, then sank by 207.33% to -$9.1 million in 2023, then soared by 164.91% to $5.9 million in 2024, then slumped by 379.83% to -$16.5 million in 2025, then fell by 13.84% to -$18.7 million in 2026.
• Business Quant data shows FBRX's Change in Cash at -$18.7 million in Q1 2026, -$16.5 million in Q4 2025, and -$12.7 million in Q3 2025.